Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Equity Average: 2011-2025

Historic Equity Average for ProPhase Labs (PRPH) over the last 14 years, with Sep 2025 value amounting to $9.1 million.

  • ProPhase Labs' Equity Average fell 77.74% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year decrease of 77.74%. This contributed to the annual value of $28.4 million for FY2024, which is 49.80% down from last year.
  • Per ProPhase Labs' latest filing, its Equity Average stood at $9.1 million for Q3 2025, which was down 31.10% from $13.3 million recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Equity Average ranged from a high of $68.0 million in Q3 2022 and a low of $9.1 million during Q3 2025.
  • Over the past 3 years, ProPhase Labs' median Equity Average value was $44.5 million (recorded in 2024), while the average stood at $38.3 million.
  • As far as peak fluctuations go, ProPhase Labs' Equity Average spiked by 401.44% in 2021, and later crashed by 77.74% in 2025.
  • Quarterly analysis of 5 years shows ProPhase Labs' Equity Average stood at $53.4 million in 2021, then grew by 23.07% to $65.8 million in 2022, then declined by 19.57% to $52.9 million in 2023, then slumped by 57.02% to $22.7 million in 2024, then crashed by 77.74% to $9.1 million in 2025.
  • Its last three reported values are $9.1 million in Q3 2025, $13.3 million for Q2 2025, and $11.2 million during Q1 2025.